In the latest trading session, Novavax (NVAX) closed at $4.33, marking a +0.93% move from the previous day. This move outpaced the S&P 500's daily loss of 1.57%. Elsewhere, the Dow saw a downswing of ...
Founded in 1993, The Motley Fool is a financial services company dedicated to making the world smarter, happier, and richer.
In a letter seen by MarketWatch, the activist fund blamed the sharp drop in Novavax’s sales on the U.S. vaccine-maker’s ...
The R21/Matrix-M vaccine, developed by Oxford University and the Serum Institute of India, leveraging Novavax’s Matrix-M ...
InvestorPlace - Stock Market News, Stock Advice & Trading Tips If you have a high tolerance for volatility then the biotech ...
Harmony Biosciences is adding a suite of epilepsy assets to its pipeline, buying Epygenix for $35 million upfront with more ...
Novavax ( NVAX 2.06%) was once a top-performing vaccine stock, soaring more than 2,000% in 2020 on optimism about its ...
Two Christian health-care workers in Virginia lost their claims that Inova Health Systems’ denial of their requests for ...
A team of Montana researchers is playing a key role in the development of a more effective vaccine against tuberculosis, an ...
NEW YORK, NY / ACCESSWIRE / April 25, 2024 / Levi & Korsinsky informs shareholders that a settlement has been reached in the pending class ...
Following a meeting of an advisory panel this week, the World Health Organization (WHO) recommended drugmakers to update ...
Shah Capital, a major shareholder in Novavax, urges board shake-up citing underperformance and failure to maximize ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results